Hospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2012

  1. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors

    Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704

  2. Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy

    Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427

2011

  1. A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis

    Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 219-225

2008

  1. Molecular bases of the fetal liver - Placenta - Maternal liver excretory pathway for cholephilic compounds

    Liver International, Vol. 28, Núm. 4, pp. 435-454

  2. Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy

    Toxicology and Applied Pharmacology, Vol. 232, Núm. 2, pp. 327-336

2007

  1. Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification

    Toxicology, Vol. 232, Núm. 1-2, pp. 24-36

2006

  1. Excretion of fetal biliverdin by the rat placenta-maternal liver tandem

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 290, Núm. 3

2005

  1. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis

    Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 2, pp. 751-758

1983

  1. Serum glycosidases in diabetes mellitus in relation to the retinopathy and to the length of the disease

    Clinica Chimica Acta, Vol. 132, Núm. 1, pp. 23-27